Results 201 to 210 of about 950,403 (244)
Some of the next articles are maybe not open access.
Hematology/Oncology Clinics of North America, 2007
Medullary thyroid carcinoma is a neuroendocrine tumor derived from the C cells of the thyroid gland and accounts for approximately 5% of all thyroid carcinomas. Approximately 30% of the cases are associated with an autosomal dominant syndrome called multiple endocrine neoplasia type 2, and the identification of these individuals is important because ...
Ana O, Hoff, Paulo M, Hoff
openaire +2 more sources
Medullary thyroid carcinoma is a neuroendocrine tumor derived from the C cells of the thyroid gland and accounts for approximately 5% of all thyroid carcinomas. Approximately 30% of the cases are associated with an autosomal dominant syndrome called multiple endocrine neoplasia type 2, and the identification of these individuals is important because ...
Ana O, Hoff, Paulo M, Hoff
openaire +2 more sources
Current Treatment Options in Oncology, 2003
Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy that occurs in hereditary (25%) and sporadic (75%) clinical settings. MTC is present in all patients with the multiple endocrine neoplasia type 2 syndromes. MTCs produce calcitonin, the measurement of which can indicate the presence of tumors in people who are at risk and the ...
openaire +2 more sources
Medullary thyroid carcinoma (MTC) is a neuroendocrine malignancy that occurs in hereditary (25%) and sporadic (75%) clinical settings. MTC is present in all patients with the multiple endocrine neoplasia type 2 syndromes. MTCs produce calcitonin, the measurement of which can indicate the presence of tumors in people who are at risk and the ...
openaire +2 more sources
Endocrine Practice, 2013
This review outlines advances in the diagnosis, genetic testing, and progress in medullary thyroid cancer (MTC) treatment in light of the most recent evidence.English-language articles pertaining to MTC published up to 2012 were reviewed. The pertinent articles and their references were obtained and those considered relevant were reviewed for inclusion.
Marcio L, Griebeler +2 more
openaire +2 more sources
This review outlines advances in the diagnosis, genetic testing, and progress in medullary thyroid cancer (MTC) treatment in light of the most recent evidence.English-language articles pertaining to MTC published up to 2012 were reviewed. The pertinent articles and their references were obtained and those considered relevant were reviewed for inclusion.
Marcio L, Griebeler +2 more
openaire +2 more sources
2016
Renal medullary carcinoma (RMC) is a rare and aggressive form of non-clear cell kidney cancer that typically affects young adults and is almost exclusively associated with sickle cell trait. It has only been recognized in the last two decades and continues to be relatively poorly understood.
Pai, Sachin, Matrana, Marc R.
openaire +3 more sources
Renal medullary carcinoma (RMC) is a rare and aggressive form of non-clear cell kidney cancer that typically affects young adults and is almost exclusively associated with sickle cell trait. It has only been recognized in the last two decades and continues to be relatively poorly understood.
Pai, Sachin, Matrana, Marc R.
openaire +3 more sources
Medullary carcinoma of the breast
Cancer Treatment Reviews, 1988Medullary carcinoma of the breast (MC) was primarily characterized histopathologically in the late 1940s. Until then, the word 'medullary'-when applied to mammary car- cinoma-had been used with different meaning by various writers. As early as 1945, Geschichter (16) mentioned in a textbook of pathology the 'so-called medullary cancers' under a heading ...
L, Pedersen, S, Holck, T, Schiødt
openaire +2 more sources
Medullary Carcinoma of the Thyroid
Archives of Otolaryngology - Head and Neck Surgery, 1983Medullary cancer of the thyroid is rare but of unusual biologic interest. It originates in the thyroid parafollicular or C cells that are of neural crest origin and that secrete calcitonin. Calcitonin measurements, particularly after pentagastrim administration, are useful in detecting the tumor and following its progression.
openaire +2 more sources
2011
Abstract Medullary thyroid carcinoma (MTC) is a rare calcitonin-secreting tumour of the parafollicular or C cells of the thyroid. As the C cells originate from the embryonic neural crest, MTC often have the clinical and histological features of neuroendocrine tumours.
Friedhelm Raue, Karin Frank-Raue
openaire +1 more source
Abstract Medullary thyroid carcinoma (MTC) is a rare calcitonin-secreting tumour of the parafollicular or C cells of the thyroid. As the C cells originate from the embryonic neural crest, MTC often have the clinical and histological features of neuroendocrine tumours.
Friedhelm Raue, Karin Frank-Raue
openaire +1 more source
Medullary carcinoma of the thyroid
World Journal of Surgery, 1981AbstractMedullary carcinoma of the thyroid (MCT) is a rare tumor which, since its identification by Hazard et al. [2] in 1959, has attracted interest for 2 reasons. First, the secretion of the tumor marker, thyrocalcitonin, provides a means of making the diagnosis of MCT before the tumor is clinically evident.
J, Lynn, O I, Gamvros, S, Taylor
openaire +2 more sources
Journal of Surgical Oncology, 1975
AbstractMedullary thyroid carcinoma is an infrequent and unusual malignancy. Since its description 15 years ago, many new features have developed. Many biologically active compounds which are directly related to the different symptoms of the disease have been recovered from the tumors.
A C, Raynor, D, Sowden
openaire +2 more sources
AbstractMedullary thyroid carcinoma is an infrequent and unusual malignancy. Since its description 15 years ago, many new features have developed. Many biologically active compounds which are directly related to the different symptoms of the disease have been recovered from the tumors.
A C, Raynor, D, Sowden
openaire +2 more sources
Medullary Carcinoma and Pheochromocytoma
JAMA: The Journal of the American Medical Association, 1978To the Editor.— In the article by Ram et al (239:2155, 1978) it is suggested that medullary carcinoma is the only histologic variety of malignant thyroid tumor that is associated with pheochromocytoma. Occult sclerosing papillary carcinoma has been reported in two patients with pheochromocytoma.
openaire +2 more sources